Björn Stork
0000-0002-4167-7806
Düsseldorf University Hospital
6 papers found
Refreshing results…
Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs)
High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol
Carbamoyl-Phosphate Synthase 1 as a Novel Target of Phomoxanthone A, a Bioactive Fungal Metabolite
First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2′,4′-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy
Systematic analysis of ATG13 domain requirements for autophagy induction
The mycotoxin phomoxanthone A disturbs the form and function of the inner mitochondrial membrane
Missing publications? Search for publications with a matching author name.